Free Trial

Advanced Medical Solutions Group (AMS) Competitors

GBX 217
+1.00 (+0.46%)
(As of 05/31/2024 ET)

AMS vs. TSTL, BVC, SPEC, AKR, CNSL, ODX, CTEC, CLIN, EMIS, and GNS

Should you be buying Advanced Medical Solutions Group stock or one of its competitors? The main competitors of Advanced Medical Solutions Group include Tristel (TSTL), BATM Advanced Communications (BVC), INSPECS Group (SPEC), Akers Biosciences (AKR), Cambridge Nutritional Sciences (CNSL), Omega Diagnostics Group (ODX), ConvaTec Group (CTEC), Clinigen Group (CLIN), EMIS Group (EMIS), and Genus (GNS). These companies are all part of the "medical" sector.

Advanced Medical Solutions Group vs.

Advanced Medical Solutions Group (LON:AMS) and Tristel (LON:TSTL) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, community ranking, institutional ownership, analyst recommendations, risk, profitability and earnings.

Advanced Medical Solutions Group pays an annual dividend of GBX 2 per share and has a dividend yield of 0.9%. Tristel pays an annual dividend of GBX 13 per share and has a dividend yield of 3.1%. Advanced Medical Solutions Group pays out 2,857.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Tristel pays out 10,000.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Advanced Medical Solutions Group has higher revenue and earnings than Tristel. Advanced Medical Solutions Group is trading at a lower price-to-earnings ratio than Tristel, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Advanced Medical Solutions Group£126.21M3.68£15.89M£0.073,100.00
Tristel£39.49M5.06£6.04M£0.133,230.77

In the previous week, Advanced Medical Solutions Group had 1 more articles in the media than Tristel. MarketBeat recorded 2 mentions for Advanced Medical Solutions Group and 1 mentions for Tristel. Tristel's average media sentiment score of 0.59 beat Advanced Medical Solutions Group's score of 0.36 indicating that Tristel is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Advanced Medical Solutions Group
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Tristel
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Advanced Medical Solutions Group received 16 more outperform votes than Tristel when rated by MarketBeat users. However, 57.36% of users gave Tristel an outperform vote while only 49.70% of users gave Advanced Medical Solutions Group an outperform vote.

CompanyUnderperformOutperform
Advanced Medical Solutions GroupOutperform Votes
164
49.70%
Underperform Votes
166
50.30%
TristelOutperform Votes
148
57.36%
Underperform Votes
110
42.64%

Tristel has a net margin of 15.29% compared to Advanced Medical Solutions Group's net margin of 12.59%. Tristel's return on equity of 20.35% beat Advanced Medical Solutions Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Advanced Medical Solutions Group12.59% 6.61% 4.14%
Tristel 15.29%20.35%9.89%

Advanced Medical Solutions Group has a beta of 0.57, indicating that its share price is 43% less volatile than the S&P 500. Comparatively, Tristel has a beta of 0.26, indicating that its share price is 74% less volatile than the S&P 500.

Advanced Medical Solutions Group currently has a consensus price target of GBX 300, suggesting a potential upside of 38.25%. Given Advanced Medical Solutions Group's higher possible upside, analysts clearly believe Advanced Medical Solutions Group is more favorable than Tristel.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Advanced Medical Solutions Group
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Tristel
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

65.7% of Advanced Medical Solutions Group shares are owned by institutional investors. Comparatively, 50.2% of Tristel shares are owned by institutional investors. 2.6% of Advanced Medical Solutions Group shares are owned by company insiders. Comparatively, 5.3% of Tristel shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Tristel beats Advanced Medical Solutions Group on 10 of the 19 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AMS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AMS vs. The Competition

MetricAdvanced Medical Solutions GroupMedical Instruments & Supplies IndustryMedical SectorLON Exchange
Market Cap£464.84M£3.50B£5.17B£1.80B
Dividend Yield1.09%1.91%2.76%5.78%
P/E Ratio3,100.00330.07112.932,057.20
Price / Sales3.68159.522,390.49348,490.05
Price / Cash7.87134.5835.4927.08
Price / Book1.903.165.542.77
Net Income£15.89M£101.94M£106.07M£171.01M
7 Day Performance1.88%-0.77%1.15%0.17%
1 Month Performance12.44%2.08%0.65%3.25%
1 Year Performance-7.15%-8.31%2.70%14.89%

Advanced Medical Solutions Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TSTL
Tristel
0 of 5 stars
GBX 432
+2.2%
N/A+15.4%£205.37M£39.49M3,323.08208
BVC
BATM Advanced Communications
0 of 5 stars
GBX 18.50
flat
N/A-27.8%£80.70M£122.83M2,800.00980News Coverage
Positive News
Gap Down
SPEC
INSPECS Group
0 of 5 stars
GBX 72.05
+0.1%
N/A-36.1%£73.25M£203.29M-7,205.001,673
AKR
Akers Biosciences
0 of 5 stars
GBX 57.50
flat
N/AN/A£21.64M£2.32M-0.4432
CNSL
Cambridge Nutritional Sciences
0 of 5 stars
GBX 4.24
+3.2%
N/AN/A£10.09M£9.05M-424.0091
ODX
Omega Diagnostics Group
0 of 5 stars
GBX 2.20
flat
N/A-12.0%£5.23M£7.55M-220.0091Gap Down
CTEC
ConvaTec Group
1.2318 of 5 stars
GBX 253.40
+1.0%
GBX 307.17
+21.2%
+19.2%£5.19B£2.14B5,068.0010,136News Coverage
CLIN
Clinigen Group
0 of 5 stars
GBX 925
flat
N/AN/A£1.23B£565.60M64.691,000
EMIS
EMIS Group
0 of 5 stars
GBX 1,920
flat
N/A+45.5%£1.23B£176.86M4,085.111,560
GNS
Genus
0 of 5 stars
GBX 1,780
-3.6%
N/A-28.4%£1.18B£673.10M3,490.203,500

Related Companies and Tools

This page (LON:AMS) was last updated on 6/2/2024 by MarketBeat.com Staff

From Our Partners